Skip to content
  • Home
  • About
  • software studies
  • business strategy
  • global affairs
  • newsletter
  • Contact

chumbo.news

We create multiplayer stories.

Posted on August 1, 2021

BioNTech aims to develop the first mRNA malaria vaccine as well as the capacity to produce it in Africa

Reuters/James Gathany/CDCAfrica stands to benefit the most from a malaria vaccine given the high prevalence rates.

https://qz.com/africa/2040120/biontech-to-develop-the-first-mrna-malaria-vaccine/

Related

Published by: chumbovisions

chumbo.org View all posts by chumbovisions

Categories linkTagsafrica, biotech, health, malaria, mrna, pandemics, vaccines

Post navigation

Previous Previous post: Recognizing People in Photos Through Private On-Device Machine Learning
Next Next post: Allegations, lawsuits and damning reports: How Frontex became the most contentious EU agency

Menu

  • Home
  • About
  • software studies
  • business strategy
  • global affairs
  • newsletter
  • Contact